217 related articles for article (PubMed ID: 18311533)
21. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026
[TBL] [Abstract][Full Text] [Related]
22. Bilateral breasts involvement in Burkitt's lymphoma detected only by FDG-PET.
Kyoung Jung H; Kim EK; Yun M; Jung Kim M; Young Kwak J
Clin Imaging; 2006; 30(1):57-9. PubMed ID: 16377487
[TBL] [Abstract][Full Text] [Related]
23. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory F-18 FDG uptake secondary to ruptured breast prosthesis.
Bhargava P; Glass E; Ghesani M
Clin Nucl Med; 2006 Apr; 31(4):227-8. PubMed ID: 16550024
[TBL] [Abstract][Full Text] [Related]
25. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.
Blebea JS; Houseni M; Torigian DA; Fan C; Mavi A; Zhuge Y; Iwanaga T; Mishra S; Udupa J; Zhuang J; Gopal R; Alavi A
Semin Nucl Med; 2007 May; 37(3):185-94. PubMed ID: 17418151
[TBL] [Abstract][Full Text] [Related]
26. Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study.
Kojima S; Zhou B; Teramukai S; Hara A; Kosaka N; Matsuo Y; Suzuki H; Torigoe S; Suzuki T; Uno K; Fukushima M
Eur J Cancer; 2007 Aug; 43(12):1842-8. PubMed ID: 17614273
[TBL] [Abstract][Full Text] [Related]
27. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.
Nishizawa S; Kojima S; Teramukai S; Inubushi M; Kodama H; Maeda Y; Okada H; Zhou B; Nagai Y; Fukushima M
J Clin Oncol; 2009 Apr; 27(11):1767-73. PubMed ID: 19255324
[TBL] [Abstract][Full Text] [Related]
29. A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Marshall C; Mustafa S; Wheatley DC; Eremin JE; El-Sheemy M; Jibril JA; Eremin O; Griffiths PA
Nucl Med Commun; 2004 Jul; 25(7):721-5. PubMed ID: 15208500
[TBL] [Abstract][Full Text] [Related]
30. The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening.
Shen YY; Su CT; Chen GJ; Chen YK; Liao AC; Tsai FS
Neoplasma; 2003; 50(3):217-21. PubMed ID: 12937856
[TBL] [Abstract][Full Text] [Related]
31. Preliminary clinical applications of a device-dedicated whole-body positron emission tomography reconstruction method: impact on standardized uptake values.
Daouk J; Bailly P; Fin L; Meyer ME
Nucl Med Commun; 2010 Sep; 31(9):793-9. PubMed ID: 20634766
[TBL] [Abstract][Full Text] [Related]
32. Cancer screening with FDG-PET.
Ide M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):23-7. PubMed ID: 16557201
[TBL] [Abstract][Full Text] [Related]
33. Whole-body PET/CT-mammography for staging breast cancer: initial results.
Heusner TA; Freudenberg LS; Kuehl H; Hauth EA; Veit-Haibach P; Forsting M; Bockisch A; Antoch G
Br J Radiol; 2008 Sep; 81(969):743-8. PubMed ID: 18508873
[TBL] [Abstract][Full Text] [Related]
34. Some issues in screening for breast and other cancers.
Duffy SW; McCann J; Godward S; Gabe R; Warwick J
J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Teixeira SC; Rebolleda JF; Koolen BB; Wesseling J; Jurado RS; Stokkel MP; Del Puig Cózar Santiago M; van der Noort V; Rutgers EJ; Valdés Olmos RA
AJR Am J Roentgenol; 2016 Jun; 206(6):1307-14. PubMed ID: 27058014
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer: pre- and postoperative imaging for staging.
Hansen NM; Growney A
Surg Oncol Clin N Am; 2007 Apr; 16(2):447-63. PubMed ID: 17560522
[TBL] [Abstract][Full Text] [Related]
37. Evolving role of imaging modalities in inflammatory breast cancer.
Le-Petross CH; Bidaut L; Yang WT
Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
[TBL] [Abstract][Full Text] [Related]
38. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine.
Niederkohr RD; Quon A
Clin Nucl Med; 2007 Apr; 32(4):302-3. PubMed ID: 17413580
[No Abstract] [Full Text] [Related]
39. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
40. Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.
Canevari C; Gallivanone F; Zuber V; Marassi A; Losio C; Gianolli L; Gilardi MC; Castiglioni I
Clin Imaging; 2015; 39(3):506-9. PubMed ID: 25620014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
